Circulating sphingolipid biomarkers in models of type 1 diabetes
Open Access
- 1 March 2011
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 52 (3), 509-517
- https://doi.org/10.1194/jlr.m010595
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levelsJournal of Lipid Research, 2010
- Nonobese, insulin-deficient Ins2Akitamice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodelingAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Diabetes Alters Sphingolipid Metabolism in the RetinaDiabetes, 2006
- Sphingosine-1 Phosphate Prevents Monocyte/Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S1P1 ReceptorCirculation Research, 2006
- Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesityJournal of Lipid Research, 2006
- Detailed Characterization of the Lipid Composition of Detergent-Resistant Membranes from Photoreceptor Rod Outer Segment MembranesPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2005
- Relationships Between Serum Unsaturated Fatty Acids and Coronary Risk Factors Negative Relations Between Nervonic Acid and Obesity-Related Risk FactorsInternational Heart Journal, 2005
- Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart RateJournal of Biological Chemistry, 2004
- Predicting obstructive coronary artery disease with serum sphingosine-1-phosphateAmerican Heart Journal, 2003
- Nervonic acid and demyelinating diseaseMedical Hypotheses, 1994